 | • レポートコード：20QY06-05448 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、口腔粘膜炎薬のグローバル市場について種類別（マウスウォッシュ、鎮痛薬、その他）、用途別（化学療法、放射線療法）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・口腔粘膜炎薬市場の概要 ・世界の主要地域別口腔粘膜炎薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の口腔粘膜炎薬市場規模2015-2026：種類別（マウスウォッシュ、鎮痛薬、その他） ・世界の口腔粘膜炎薬市場規模2015-2026：用途別（化学療法、放射線療法） ・口腔粘膜炎薬の北米市場規模2015-2020 ・口腔粘膜炎薬のヨーロッパ市場規模2015-2020 ・口腔粘膜炎薬の中国市場規模2015-2020 ・口腔粘膜炎薬の日本市場規模2015-2020 ・口腔粘膜炎薬の東南アジア市場規模2015-2020 ・口腔粘膜炎薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （3M Healthcare、GSK、Pfizer、Colgate-Palmolive、Norgine、Biovitrum、Bausch Health、EUSA Pharma、Camurus、Mission Pharmacal、Clinigen Group、Midatech Pharma、Alliance Pharma、AMAG Pharmaceuticals） ・口腔粘膜炎薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・口腔粘膜炎薬の市場動向・機会・課題 ・調査の結論 |
Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemotherapy process in cancer patients. Oral mucositis leads to different problems such as severe pain in mouth, lack of nutrition due to inability to eat, increased risk of infections due to open sores in the oral cavity. The disease usually lasts for one week to six weeks or more.
The classification of Oral Mucositis Drugs includes Mouthwash, Pain Control Medication and Other, the sales of Mouthwash are 16.9 million units, with its market share 48.8%. And the sales market share of Pain Control Medication is 38% in 2017.
Oral Mucositis Drugs is widely used to Chemotherapy Oral Mucositis and Radiotherapy Oral Mucositis. The most proportion of Oral Mucositis Drugs is to Radiotherapy Oral Mucositis, and the proportion is about 69.6% in 2017.
North America region is the largest supplier of Oral Mucositis Drugs, with a production market share nearly 53.6% in 2017. Europe is the second largest supplier of Oral Mucositis Drugs, enjoying production market share nearly 33.2% in 2017.
North America is the largest sales place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 26.9% in 2017. China is an important market of Oral Mucositis Drugs in Asia, accounting for 7.6% sales market share of global market.
Market Analysis and Insights: Global Oral Mucositis Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oral Mucositis Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Oral Mucositis Drugs industry.
Based on our recent survey, we have several different scenarios about the Oral Mucositis Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 476.5 million in 2019. The market size of Oral Mucositis Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Oral Mucositis Drugs Scope and Market Size
The global Oral Mucositis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Mucositis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Mucositis Drugs market is segmented into
Mouthwash
Pain Control Medication
Other
Segment by Application, the Oral Mucositis Drugs market is segmented into
Chemotherapy
Radiotherapy
The Oral Mucositis Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Oral Mucositis Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Mucositis Drugs Market Share Analysis
Oral Mucositis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Mucositis Drugs business, the date to enter into the Oral Mucositis Drugs market, Oral Mucositis Drugs product introduction, recent developments, etc.
The major vendors covered:
3M Healthcare
GSK
Pfizer
Colgate-Palmolive
Norgine
Biovitrum
Bausch Health
EUSA Pharma
Camurus
Mission Pharmacal
Clinigen Group
Midatech Pharma
Alliance Pharma
AMAG Pharmaceuticals
1 Oral Mucositis Drugs Market Overview
1.1 Oral Mucositis Drugs Product Scope
1.2 Oral Mucositis Drugs Segment by Type
1.2.1 Global Oral Mucositis Drugs Sales by Type (2020-2026)
1.2.2 Mouthwash
1.2.3 Pain Control Medication
1.2.4 Other
1.3 Oral Mucositis Drugs Segment by Application
1.3.1 Global Oral Mucositis Drugs Sales Comparison by Application (2020-2026)
1.3.2 Chemotherapy
1.3.3 Radiotherapy
1.4 Oral Mucositis Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Oral Mucositis Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Oral Mucositis Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Oral Mucositis Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Oral Mucositis Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Oral Mucositis Drugs Industry
1.5.1.1 Oral Mucositis Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Oral Mucositis Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Oral Mucositis Drugs Players to Combat Covid-19 Impact
2 Oral Mucositis Drugs Estimate and Forecast by Region
2.1 Global Oral Mucositis Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Oral Mucositis Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Oral Mucositis Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Oral Mucositis Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Oral Mucositis Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Oral Mucositis Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Oral Mucositis Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Oral Mucositis Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Oral Mucositis Drugs Estimates and Projections (2015-2026)
2.4.3 China Oral Mucositis Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Oral Mucositis Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Oral Mucositis Drugs Estimates and Projections (2015-2026)
2.4.6 India Oral Mucositis Drugs Estimates and Projections (2015-2026)
3 Global Oral Mucositis Drugs Competition Landscape by Players
3.1 Global Top Oral Mucositis Drugs Players by Sales (2015-2020)
3.2 Global Top Oral Mucositis Drugs Players by Revenue (2015-2020)
3.3 Global Oral Mucositis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Mucositis Drugs as of 2019)
3.4 Global Oral Mucositis Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Oral Mucositis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Oral Mucositis Drugs Players (Opinion Leaders)
4 Global Oral Mucositis Drugs Market Size by Type
4.1 Global Oral Mucositis Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Oral Mucositis Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Oral Mucositis Drugs Price by Type (2014-2020)
4.2 Global Oral Mucositis Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Oral Mucositis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Mucositis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Oral Mucositis Drugs Price Forecast by Type (2021-2026)
5 Global Oral Mucositis Drugs Market Size by Application
5.1 Global Oral Mucositis Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Oral Mucositis Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Oral Mucositis Drugs Price by Application (2015-2020)
5.2 Global Oral Mucositis Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Oral Mucositis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Mucositis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Mucositis Drugs Price Forecast by Application (2021-2026)
3 North America Oral Mucositis Drugs Market Facts & Figures
3.2 North America Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
3.3 North America Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
3.4 North America Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
4 Europe Oral Mucositis Drugs Market Facts & Figures
4.2 Europe Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
5 China Oral Mucositis Drugs Market Facts & Figures
5.2 China Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
5.3 China Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
5.4 China Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
6 Japan Oral Mucositis Drugs Market Facts & Figures
6.2 Japan Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Oral Mucositis Drugs Market Facts & Figures
7.2 Southeast Asia Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
8 India Oral Mucositis Drugs Market Facts & Figures
8.2 India Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
8.3 India Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
8.4 India Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Oral Mucositis Drugs Business
12.1 3M Healthcare
12.1.1 3M Healthcare Oral Mucositis Drugs Corporation Information
12.1.2 3M Healthcare Oral Mucositis Drugs Business Overview and Total Revenue
12.1.3 3M Healthcare Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 3M Healthcare Oral Mucositis Drugs Products Offered
12.1.5 3M Healthcare Recent Development
12.2 GSK
12.2.1 GSK Oral Mucositis Drugs Corporation Information
12.2.2 GSK Oral Mucositis Drugs Business Overview and Total Revenue
12.2.3 GSK Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Oral Mucositis Drugs Products Offered
12.2.5 GSK Recent Development
12.3 Pfizer
12.3.1 Pfizer Oral Mucositis Drugs Corporation Information
12.3.2 Pfizer Oral Mucositis Drugs Business Overview and Total Revenue
12.3.3 Pfizer Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Oral Mucositis Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Colgate-Palmolive
12.4.1 Colgate-Palmolive Oral Mucositis Drugs Corporation Information
12.4.2 Colgate-Palmolive Oral Mucositis Drugs Business Overview and Total Revenue
12.4.3 Colgate-Palmolive Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Colgate-Palmolive Oral Mucositis Drugs Products Offered
12.4.5 Colgate-Palmolive Recent Development
12.5 Norgine
12.5.1 Norgine Oral Mucositis Drugs Corporation Information
12.5.2 Norgine Oral Mucositis Drugs Business Overview and Total Revenue
12.5.3 Norgine Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Norgine Oral Mucositis Drugs Products Offered
12.5.5 Norgine Recent Development
12.6 Biovitrum
12.6.1 Biovitrum Oral Mucositis Drugs Corporation Information
12.6.2 Biovitrum Oral Mucositis Drugs Business Overview and Total Revenue
12.6.3 Biovitrum Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biovitrum Oral Mucositis Drugs Products Offered
12.6.5 Biovitrum Recent Development
12.7 Bausch Health
12.7.1 Bausch Health Oral Mucositis Drugs Corporation Information
12.7.2 Bausch Health Oral Mucositis Drugs Business Overview and Total Revenue
12.7.3 Bausch Health Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bausch Health Oral Mucositis Drugs Products Offered
12.7.5 Bausch Health Recent Development
12.8 EUSA Pharma
12.8.1 EUSA Pharma Oral Mucositis Drugs Corporation Information
12.8.2 EUSA Pharma Oral Mucositis Drugs Business Overview and Total Revenue
12.8.3 EUSA Pharma Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 EUSA Pharma Oral Mucositis Drugs Products Offered
12.8.5 EUSA Pharma Recent Development
12.9 Camurus
12.9.1 Camurus Oral Mucositis Drugs Corporation Information
12.9.2 Camurus Oral Mucositis Drugs Business Overview and Total Revenue
12.9.3 Camurus Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Camurus Oral Mucositis Drugs Products Offered
12.9.5 Camurus Recent Development
12.10 Mission Pharmacal
12.10.1 Mission Pharmacal Oral Mucositis Drugs Corporation Information
12.10.2 Mission Pharmacal Oral Mucositis Drugs Business Overview and Total Revenue
12.10.3 Mission Pharmacal Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mission Pharmacal Oral Mucositis Drugs Products Offered
12.10.5 Mission Pharmacal Recent Development
12.11 Clinigen Group
12.11.1 Clinigen Group Oral Mucositis Drugs Corporation Information
12.11.2 Clinigen Group Oral Mucositis Drugs Business Overview and Total Revenue
12.11.3 Clinigen Group Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Clinigen Group Oral Mucositis Drugs Products Offered
12.11.5 Clinigen Group Recent Development
12.12 Midatech Pharma
12.12.1 Midatech Pharma Oral Mucositis Drugs Corporation Information
12.12.2 Midatech Pharma Oral Mucositis Drugs Business Overview and Total Revenue
12.12.3 Midatech Pharma Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Midatech Pharma Oral Mucositis Drugs Products Offered
12.12.5 Midatech Pharma Recent Development
12.13 Alliance Pharma
12.13.1 Alliance Pharma Oral Mucositis Drugs Corporation Information
12.13.2 Alliance Pharma Oral Mucositis Drugs Business Overview and Total Revenue
12.13.3 Alliance Pharma Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Alliance Pharma Oral Mucositis Drugs Products Offered
12.13.5 Alliance Pharma Recent Development
12.14 AMAG Pharmaceuticals
12.14.1 AMAG Pharmaceuticals Oral Mucositis Drugs Corporation Information
12.14.2 AMAG Pharmaceuticals Oral Mucositis Drugs Business Overview and Total Revenue
12.14.3 AMAG Pharmaceuticals Oral Mucositis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 AMAG Pharmaceuticals Oral Mucositis Drugs Products Offered
12.14.5 AMAG Pharmaceuticals Recent Development
13 Oral Mucositis Drugs Manufacturing Cost Analysis
13.1 Oral Mucositis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oral Mucositis Drugs
13.4 Oral Mucositis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oral Mucositis Drugs Distributors List
14.3 Oral Mucositis Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Oral Mucositis Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Oral Mucositis Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Oral Mucositis Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Oral Mucositis Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Oral Mucositis Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Oral Mucositis Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Oral Mucositis Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Oral Mucositis Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Oral Mucositis Drugs Revenue Share by Region (2015-2020)
Table 13. Global Oral Mucositis Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Oral Mucositis Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Oral Mucositis Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Oral Mucositis Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Oral Mucositis Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Oral Mucositis Drugs Sales Share by Company (2015-2020)
Table 19. Global Oral Mucositis Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Oral Mucositis Drugs Revenue Share by Company (2015-2020)
Table 21. Global Oral Mucositis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Mucositis Drugs as of 2019)
Table 22. Global Oral Mucositis Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Oral Mucositis Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Oral Mucositis Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Oral Mucositis Drugs Players
Table 27. Global Oral Mucositis Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Oral Mucositis Drugs Sales Share by Type (2015-2020)
Table 29. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Oral Mucositis Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Oral Mucositis Drugs Sales Share by Type (2021-2026)
Table 32. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Oral Mucositis Drugs Revenue Share by Type (2021-2026)
Table 34. Global Oral Mucositis Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Oral Mucositis Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Oral Mucositis Drugs Sales Share by Application (2015-2020)
Table 37. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Oral Mucositis Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Oral Mucositis Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Oral Mucositis Drugs Sales Share by Application (2021-2026)
Table 41. Global Oral Mucositis Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Oral Mucositis Drugs Revenue Share by Application (2021-2026)
Table 43. Global Oral Mucositis Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Oral Mucositis Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Oral Mucositis Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Oral Mucositis Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Oral Mucositis Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Oral Mucositis Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Oral Mucositis Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
Table 56. China Oral Mucositis Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
Table 58. China Oral Mucositis Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
Table 60. China Oral Mucositis Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Oral Mucositis Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Oral Mucositis Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Oral Mucositis Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Oral Mucositis Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Oral Mucositis Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Oral Mucositis Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
Table 74. India Oral Mucositis Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Oral Mucositis Drugs Sales Market Share by Company (2015-2020)
Table 76. India Oral Mucositis Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Oral Mucositis Drugs Sales Market Share by Type (2015-2020)
Table 78. India Oral Mucositis Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Oral Mucositis Drugs Sales Market Share by Application (2015-2020)
Table 80. 3M Healthcare Corporation Information
Table 81. 3M Healthcare Description and Business Overview
Table 82. 3M Healthcare Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. 3M Healthcare Oral Mucositis Drugs Product
Table 84. 3M Healthcare Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GSK Oral Mucositis Drugs Product
Table 89. GSK Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pfizer Oral Mucositis Drugs Product
Table 94. Pfizer Recent Development
Table 95. Colgate-Palmolive Corporation Information
Table 96. Colgate-Palmolive Description and Business Overview
Table 97. Colgate-Palmolive Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Colgate-Palmolive Oral Mucositis Drugs Product
Table 99. Colgate-Palmolive Recent Development
Table 100. Norgine Corporation Information
Table 101. Norgine Description and Business Overview
Table 102. Norgine Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Norgine Oral Mucositis Drugs Product
Table 104. Norgine Recent Development
Table 105. Biovitrum Corporation Information
Table 106. Biovitrum Description and Business Overview
Table 107. Biovitrum Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Biovitrum Oral Mucositis Drugs Product
Table 109. Biovitrum Recent Development
Table 110. Bausch Health Corporation Information
Table 111. Bausch Health Description and Business Overview
Table 112. Bausch Health Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Bausch Health Oral Mucositis Drugs Product
Table 114. Bausch Health Recent Development
Table 115. EUSA Pharma Corporation Information
Table 116. EUSA Pharma Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. EUSA Pharma Description and Business Overview
Table 118. EUSA Pharma Oral Mucositis Drugs Product
Table 119. EUSA Pharma Recent Development
Table 120. Camurus Corporation Information
Table 121. Camurus Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Camurus Description and Business Overview
Table 123. Camurus Oral Mucositis Drugs Product
Table 124. Camurus Recent Development
Table 125. Mission Pharmacal Corporation Information
Table 126. Mission Pharmacal Description and Business Overview
Table 127. Mission Pharmacal Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Mission Pharmacal Oral Mucositis Drugs Product
Table 129. Mission Pharmacal Recent Development
Table 130. Clinigen Group Corporation Information
Table 131. Clinigen Group Description and Business Overview
Table 132. Clinigen Group Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Clinigen Group Oral Mucositis Drugs Product
Table 134. Clinigen Group Recent Development
Table 135. Midatech Pharma Corporation Information
Table 136. Midatech Pharma Description and Business Overview
Table 137. Midatech Pharma Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Midatech Pharma Oral Mucositis Drugs Product
Table 139. Midatech Pharma Recent Development
Table 140. Alliance Pharma Corporation Information
Table 141. Alliance Pharma Description and Business Overview
Table 142. Alliance Pharma Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Alliance Pharma Oral Mucositis Drugs Product
Table 144. Alliance Pharma Recent Development
Table . AMAG Pharmaceuticals Corporation Information
Table . AMAG Pharmaceuticals Description and Business Overview
Table . AMAG Pharmaceuticals Oral Mucositis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . AMAG Pharmaceuticals Oral Mucositis Drugs Product
Table . AMAG Pharmaceuticals Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Oral Mucositis Drugs Distributors List
Table 153. Oral Mucositis Drugs Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Mucositis Drugs Product Picture
Figure 2. Global Oral Mucositis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oral Mucositis Drugs Market Share by Application in 2020 & 2026
Figure 6. Chemotherapy Examples
Figure 7. Radiotherapy Examples
Figure 8. Global Oral Mucositis Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Oral Mucositis Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Oral Mucositis Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Oral Mucositis Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Oral Mucositis Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Oral Mucositis Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Oral Mucositis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Oral Mucositis Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Oral Mucositis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Oral Mucositis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Oral Mucositis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Oral Mucositis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Oral Mucositis Drugs Players Market Share by Revenue in Oral Mucositis Drugs 2015 & 2019
Figure 26. Oral Mucositis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Oral Mucositis Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Oral Mucositis Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Oral Mucositis Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Oral Mucositis Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Oral Mucositis Drugs Sales Market Share by Type in 2019
Figure 32. United States Oral Mucositis Drugs Sales Market Share by Type in 2019
Figure 33. Europe Oral Mucositis Drugs Sales Market Share by Company in 2019
Figure 34. Europe Oral Mucositis Drugs Sales Market Share by Type in 2019
Figure 35. Europe Oral Mucositis Drugs Sales Market Share by Application in 2019
Figure 36. China Oral Mucositis Drugs Sales Market Share by Company in 2019
Figure 37. China Oral Mucositis Drugs Sales Market Share by Type in 2019
Figure 38. China Oral Mucositis Drugs Sales Market Share by Application in 2019
Figure 39. Japan Oral Mucositis Drugs Sales Market Share by Company in 2019
Figure 40. Japan Oral Mucositis Drugs Sales Market Share by Type in 2019
Figure 41. Japan Oral Mucositis Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Oral Mucositis Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Oral Mucositis Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Oral Mucositis Drugs Sales Market Share by Application in 2019
Figure 45. India Oral Mucositis Drugs Sales Market Share by Company in 2019
Figure 46. India Oral Mucositis Drugs Sales Market Share by Type in 2019
Figure 47. India Oral Mucositis Drugs Sales Market Share by Application in 2019
Figure 48. 3M Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Colgate-Palmolive Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Norgine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Biovitrum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. EUSA Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Camurus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Mission Pharmacal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Clinigen Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Midatech Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Alliance Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Oral Mucositis Drugs
Figure 64. Manufacturing Process Analysis of Oral Mucositis Drugs
Figure 65. Oral Mucositis Drugs Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
口腔粘膜炎治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drugs for Oral Mucositis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs for Oral Mucos…- 経口薄膜薬の世界市場レポート2020 Market Analysis and Insights: Global Oral Thin Film Drugs Market The global Oral Thin Film Drugs market was valued at US$ 1975.8 million in 2019 and will reach US$ 3496.4 million by the end of 2026, growing at a CAGR of 8.4% during 2020-2026. Global Oral Thin Film Drugs Scope and Market Size The glo…
- 口唇ヘルペス（口腔ヘルペス）薬の世界市場レポート2020 Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the …
- 経口セファロスポリンの世界市場レポート2020 Market Analysis and Insights: Global Oral Cephalosporin Market The global Oral Cephalosporin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Oral Cephalosporin Scope and Market Size The global Oral Cephal…
- 経口セファロスポリンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cephalosporin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cephalosporin market …